J
Jonas Manjer
Researcher at Lund University
Publications - 384
Citations - 26240
Jonas Manjer is an academic researcher from Lund University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 84, co-authored 369 publications receiving 23177 citations. Previous affiliations of Jonas Manjer include Uppsala University & Malmö University.
Papers
More filters
Journal ArticleDOI
Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci
Juncheng Dai,Zhihua Li,Christopher I. Amos,Rayjean J. Hung,Adonina Tardón,Angeline S. Andrew,Chu Chen,David C. Christiani,Demetrios Albanes,Erik H.F.M. van der Heijden,Eric J. Duell,Gad Rennert,James McKay,Jian-Min Yuan,John K. Field,Jonas Manjer,Kjell Grankvist,Loic Le Marchand,M. Dawn Teare,Matthew B. Schabath,Melinda C. Aldrich,Ming-Sound Tsao,Philip Lazarus,Stephen Lam,Stig E. Bojesen,Stig E. Bojesen,S. M. Arnold,Xifeng Wu,Aage Haugen,Vladimir Janout,Mikael Johansson,Yonathan Brhane,Ana Fernández-Somoano,Lambertus A. Kiemeney,Michael P.A. Davies,Shanbeh Zienolddiny,Zhibin Hu,Hongbing Shen +37 more
TL;DR: A large-scale case-control study with 20 871 lung cancer cases and 15 971 controls suggested that variants in DHS might modify lung cancer susceptibility through regulating the expression of surrounding genes.
Journal ArticleDOI
Autoimmunity to selenoprotein P predicts breast cancer recurrence
Kamil Demircan,Qian Sun,Ylva C. Bengtsson,Petra Seemann,Johan Vallon-Christersson,Martin Malmberg,Lao H. Saal,Lisa Rydén,Waldemar B. Minich,Åke Borg,Jonas Manjer,Lutz Schomburg +11 more
TL;DR: In this article , low concentrations of serum selenium (Se) and its main transporter selenoprotein P (SELENOP) are associated with a poor prognosis following breast cancer diagnosis.
Journal ArticleDOI
Overweight in relation to tumour size and axillary lymph node involvement in postmenopausal breast cancer patients-differences between women invited to vs. not invited to mammography in a randomized screening trial.
TL;DR: Invitation to mammographic screening may be particularly important for overweight postmenopausal women in order to detect breast tumours early.
Journal ArticleDOI
Peripheral leucocyte count variations in rectal cancer treatment.
Louis Banka Johnson,Diya Adawi,S Sandberg,B Ottochian,C Albertsen,Jonas Manjer,Evita Zoucas,M. Bohe,Bengt Jeppsson +8 more
TL;DR: Postoperative leucocytosis is impaired after neoadjuvant radiotherapy, independent of latency period to surgery, with a marked suppression of leucocytes in the irradiated groups coupled with a reduction in leucocyte response to surgery.
Journal ArticleDOI
Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Elom K. Aglago,Ana Lucia Mayén,Viktoria Knaze,Heinz Freisling,Veronika Fedirko,David J. Hughes,Li Jiao,Anne Kirstine Eriksen,Anne Tjønneland,Marie-Christine Boutron-Ruault,Marie-Christine Boutron-Ruault,Joseph A. Rothwell,Joseph A. Rothwell,Gianluca Severi,Gianluca Severi,Gianluca Severi,Rudolf Kaaks,Verena Katzke,Matthias B. Schulze,Anna Birukov,Domenico Palli,Sabina Sieri,Maria Santucci de Magistris,Rosario Tumino,Fulvio Ricceri,Bas Bueno-de-Mesquita,Jeroen W.G. Derksen,Guri Skeie,Inger T. Gram,Torkjel M. Sandanger,J. Ramón Quirós,Leila Lujan-Barroso,María José Sánchez,Pilar Amiano,María Dolores Chirlaque,Aurelio Barricarte Gurrea,Ingegerd Johansson,Jonas Manjer,Aurora Perez-Cornago,Elisabete Weiderpass,Marc J. Gunter,Alicia K Heath,Casper G. Schalkwijk,Mazda Jenab +43 more
TL;DR: In the European Prospective Investigation into Cancer and Nutrition (EPIC) study as mentioned in this paper, the authors evaluated CRC risk associated with the intake of dAGEs and found an inverse association between dAGE intake and colorectal cancer risk.